GLP-1 drugs are widely known for treating type 2 diabetes and helping with weight loss. Now, new research suggests these medications may also play a role in lowering the risk of dementia. A large analysis published in JAMA Neurology looked closely at whether certain diabetes drugs—especially GLP-1 receptor agonists—are linked to better brain health over time. Why...
GLP-1 drugs may be the future of treating more than just diabetes. Here’s what new research reveals.
Most people recognize GLP-1 drugs for helping with weight loss and managing type 2 diabetes. But scientists are now uncovering a much broader story—these medications may benefit the heart, liver, kidneys, brain, and even influence behavior and cravings.
In this video, we explore:
✔️ How GLP-1 drugs actually work inside the body
✔️ Why they may protect organs even before weight loss happens
✔️ Their potential in treating fatty liver, Alzheimer’s, Parkinson’s, and more
✔️ What’s coming next in the GLP-1 pipeline—like monthly shots and oral versions
✔️ How future treatments could reshape chronic disease prevention
From semaglutide to tirzepatide, and newer agents like retatrutide, researchers are just beginning to understand how far these effects might reach. While these drugs are not yet approved for all these uses, clinical trials are moving fast—and the future of GLP-1s could be much bigger than anyone imagined.
The U.S. Food and Drug Administration today approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS). Waskyra is indicated for pediatric patients six months and older and adults with WAS who have a mutation in the WAS gene and for whom hematopoietic stem cell transplantation (HSCT) is...
Medications like semaglutide and liraglutide—often used for diabetes and weight loss—may also help people reduce alcohol and drug use. A new scientific review explains how these drugs affect the brain and why they might become future treatments for addiction. Researchers are still learning, but early signs are promising. Understanding Addiction and Why New...
Why Researchers Tested a Higher Dose of Semaglutide Adults with obesity often take weekly injections of the drug Semaglutide (known by brand names such as Ozempic and Wegovy) because it helps with weight loss. However, some people don’t reach their weight-loss goals with the usual dose of 2.4 mg weekly. A new study tested whether a higher dose - 7.2 mg once a...
Today, the U.S. Food and Drug Administration granted marketing authorization to Visby Medical for the Visby Medical Women’s Sexual Health Test. This is the first diagnostic test for chlamydia, gonorrhea and trichomoniasis that can be purchased without a prescription and performed entirely at home. The test is intended for females with or without symptoms and...